- Where is ERAS in the management of advanced ovarian cancer?: between myths and truths
-
Noh JJ, Lee YY
- KMID: 2537915
- J Gynecol Oncol.
- 2022 Sep;33(5):e79.
- doi: 10.3802/jgo.2022.33.e79
-
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of perioperative management of advanced ovarian (tubal/peritoneal) cancer patients: a survey from MITO-MaNGO Groups
-
Greggi S, Falcone F, Aletti GD, Cascella M, Bifulco F, Colombo N, Pignata S
- KMID: 2537909
- J Gynecol Oncol.
- 2022 Sep;33(5):e60.
- doi: 10.3802/jgo.2022.33.e60
Objective The European Society of Gynaecological Oncology (ESGO)-quality indicators (QIs) for advanced ovarian cancer (AOC) have been assessed only by few Italian centers, and data are not available on the proportion... -
- CITED
-
- Close
- SHARE
-
- Close
- Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)
-
Kobayashi Y, Masuda K, Hiraswa A, Takehara K, Tsuda H, Watanabe Y, Oda K, Nagase S, Mandai M, Okamoto A, Yaegashi N, Mikami M, Enomoto T, Aoki D, Katabuchi H, Working Group on Clinical Practice for Cancer Genomic Medicine and HBOC, Japan Society of Gynecologic Oncology
- KMID: 2537910
- J Gynecol Oncol.
- 2022 Sep;33(5):e61.
- doi: 10.3802/jgo.2022.33.e61
Objective The practices pertaining to hereditary breast and ovarian cancer (HBOC) in Japan have been rapidly changing owing to the clinical development of poly(ADP-ribose) polymerase inhibitors, the increasing availability of companion... -
- CITED
-
- Close
- SHARE
-
- Close
- The added value of SLN mapping with indocyanine green in low- and intermediate-risk endometrial cancer management: a systematic review and meta-analysis
-
Burg LC, Verheijen S, Bekkers RL, IntHout J, Holloway RW, Taskin S, Ferguson SE, Xue Y, Ditto A, Baiocchi G, Papadia A, Bogani G, Buda A, Kruitwagen RF, Zusterzeel PL
- KMID: 2537912
- J Gynecol Oncol.
- 2022 Sep;33(5):e66.
- doi: 10.3802/jgo.2022.33.e66
Objective The aim of this study was to assess the SLN detection rate in presumed early stage, low- and intermediate-risk endometrial cancers, the incidence of SLN metastases, and the negative predictive... -
- CITED
-
- Close
- SHARE
-
- Close
- Frequency and clinical features of deficient mismatch repair in ovarian clear cell and endometrioid carcinoma
-
Tanaka T, Takehara K, Yamashita N, Okazawa-Sakai M, Kuraoka K, Teramoto N, Taguchi K, Yamashiro K, Kato H, Mizunoe T, Suzuki R, Yamamoto D, Ueki A, Saito T
- KMID: 2537914
- J Gynecol Oncol.
- 2022 Sep;33(5):e67.
- doi: 10.3802/jgo.2022.33.e67
Objective To clarify the frequency of deficient mismatch repair (dMMR) in Japanese ovarian cancer patients, we examined microsatellite instability (MSI) status and immunohistochemistry (IHC) subtypes, including endometrioid carcinoma (EMC), clear cell... -
- CITED
-
- Close
- SHARE
-
- Close
- Development of a prognostic prediction support system for cervical intraepithelial neoplasia using artificial intelligence-based diagnosis
-
Takahashi T, Matsuoka H, Sakurai R, Akatsuka J, Kobayashi Y, Nakamura M, Iwata T, Banno K, Matsuzaki M, Takayama J, Aoki D, Yamamoto Y, Tamiya G
- KMID: 2537905
- J Gynecol Oncol.
- 2022 Sep;33(5):e57.
- doi: 10.3802/jgo.2022.33.e57
Objective Human papillomavirus subtypes are predictive indicators of cervical intraepithelial neoplasia (CIN) progression. While colposcopy is also an essential part of cervical cancer prevention, its accuracy and reproducibility are limited because... -
- CITED
-
- Close
- SHARE
-
- Close
- Cervical cancer patient reported gastrointestinal outcomes: intensity/volumetric modulated vs. 3D conformal radiation therapy
-
Urban R, Wong J, Lim P, Zhang S, Spadinger I, Olson R, Bachand F, Ho C, Tinker AV, Gondara L, Hamilton SN
- KMID: 2537908
- J Gynecol Oncol.
- 2022 Sep;33(5):e70.
- doi: 10.3802/jgo.2022.33.e70
Objective To evaluate gastrointestinal (GI) patient reported outcomes (PROs) in cervical cancer patients treated with definitive radiotherapy (RT), comparing 3D conformal RT (3DCRT) vs. intensity modulated/volumetric modulated arc therapy (IMRT/VMAT). Methods An analysis... -
- CITED
-
- Close
- SHARE
-
- Close
- Rotational intraperitoneal pressurized aerosol chemotherapy with paclitaxel and cisplatin: pharmacokinetics, tissue concentrations, and toxicities in a pig model
-
Park SJ, Lee EJ, Seol A, Park S, Ham J, Yim GW, Shim SH, Lim W, Chang SJ, Song G, Park JW, Kim HS, on behalf of the Korean Rotational Intraperitoneal pressurized Aerosol chemotherapy (KoRIA) Trial Group
- KMID: 2537904
- J Gynecol Oncol.
- 2022 Sep;33(5):e56.
- doi: 10.3802/jgo.2022.33.e56
Objective We used paclitaxel and cisplatin, known to be effective in intraperitoneal chemotherapy, in a novel prototype of rotational intraperitoneal pressurized aerosol chemotherapy (RIPAC) and evaluated the pharmacokinetics, tissue concentrations, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of edoxaban for the treatment of gynecological cancer-associated venous thromboembolism: analysis of Japanese real-world data
-
Odajima S, Seki T, Kato S, Tomita K, Shoburu Y, Suzuki E, Takenaka M, Saito M, Takano H, Yamada K, Okamoto A
- KMID: 2537911
- J Gynecol Oncol.
- 2022 Sep;33(5):e62.
- doi: 10.3802/jgo.2022.33.e62
Objective Direct oral anticoagulants (DOACs) are increasingly being used for the treatment of cancer-associated venous thromboembolism (CAT). However, there is limited evidence of the efficacy of DOACs for the treatment of... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic factors of dose-response relationship for nodal control in metastatic lymph nodes of cervical cancer patients undergoing definitive radiotherapy with concurrent chemotherapy
-
Lee WH, Kim GE, Kim YB
- KMID: 2537907
- J Gynecol Oncol.
- 2022 Sep;33(5):e59.
- doi: 10.3802/jgo.2022.33.e59
Objective Regional control is occasionally unsatisfactory in cervical cancer, with the optimal radiation dose for nodal metastases in definitive radiotherapy (RT) with concurrent chemotherapy (CRT) remaining controversial. We investigated dose-response relationship... -
- CITED
-
- Close
- SHARE
-
- Close
- Peritoneal dissemination of high-grade serous ovarian cancer: pivotal roles of chromosomal instability and epigenetic dynamics
-
Konishi I, Abiko K, Hayashi T, Yamanoi K, Murakami R, Yamaguchi K, Hamanishi J, Baba T, Matsumura N, Mandai M, Kyoto Study Group for Ovarian Cancer Research
- KMID: 2537916
- J Gynecol Oncol.
- 2022 Sep;33(5):e83.
- doi: 10.3802/jgo.2022.33.e83
Epithelial ovarian cancer remains the lethal gynecological malignancy in women. The representative histotype is high-grade serous carcinoma (HGSC), and most patients with HGSC present at advanced stages with peritoneal dissemination.... -
- CITED
-
- Close
- SHARE
-
- Close
- Systematic lymph node dissection during interval debulking surgery for advanced epithelial ovarian cancer: a systematic review and meta-analysis
-
Caruso G, Palaia I, Bogani G, Tomao F, Perniola G, Panici PB, Muzii L, Donato VD
- KMID: 2537913
- J Gynecol Oncol.
- 2022 Sep;33(5):e69.
- doi: 10.3802/jgo.2022.33.e69
Objective To evaluate the efficacy and safety of systematic lymph node dissection (SyLND) at the time of interval debulking surgery (IDS) for advanced epithelial ovarian cancer (AEOC). Methods Systematic literature review of studies... -
- CITED
-
- Close
- SHARE
-
- Close
- Incidence and risk factors for the development of cerebral metastasis in cervical cancer patients
-
Rangel JdB, Giglio AG, Cardozo CL, Bergmann A, Thuler LCS
- KMID: 2537906
- J Gynecol Oncol.
- 2022 Sep;33(5):e58.
- doi: 10.3802/jgo.2022.33.e58
Objective Cerebral metastasis (CM) in cervical cancer (CC) cases, although rare, results in high lethality rates. The present study aimed to assess CM incidence in a Brazilian reference CC center and... -
- CITED
-
- Close
- SHARE
-
- Close
